156 related articles for article (PubMed ID: 32362301)
1. Influence of Optic Nerve Appearance on Visual Outcome in Pediatric Idiopathic Intracranial Hypertension.
Micieli JA; Bruce BB; Vasseneix C; Blanch RJ; Berezovsky DE; Newman NJ; Biousse V; Peragallo JH
Can J Neurol Sci; 2020 Sep; 47(5):661-665. PubMed ID: 32362301
[TBL] [Abstract][Full Text] [Related]
2. Optic nerve appearance as a predictor of visual outcome in patients with idiopathic intracranial hypertension.
Micieli JA; Bruce BB; Vasseneix C; Blanch RJ; Berezovsky DE; Peragallo JH; Newman NJ; Biousse V
Br J Ophthalmol; 2019 Oct; 103(10):1429-1435. PubMed ID: 30530819
[TBL] [Abstract][Full Text] [Related]
3. Anatomic and visual function outcomes in paediatric idiopathic intracranial hypertension.
Gospe SM; Bhatti MT; El-Dairi MA
Br J Ophthalmol; 2016 Apr; 100(4):505-9. PubMed ID: 26269534
[TBL] [Abstract][Full Text] [Related]
4. Optic Nerve Angle in Idiopathic Intracranial Hypertension.
Chen BS; Asnafi S; Lin MY; Bruce BB; Lock JH; Sharma RA; Newman NJ; Biousse V; Saindane AM
J Neuroophthalmol; 2021 Dec; 41(4):e464-e469. PubMed ID: 34788243
[TBL] [Abstract][Full Text] [Related]
5. The Optic Canal Size Is Associated With the Severity of Papilledema and Poor Visual Function in Idiopathic Intracranial Hypertension.
Bidot S; Clough L; Saindane AM; Newman NJ; Biousse V; Bruce BB
J Neuroophthalmol; 2016 Jun; 36(2):120-5. PubMed ID: 26580295
[TBL] [Abstract][Full Text] [Related]
6. Rating papilloedema: an evaluation of the Frisén classification in idiopathic intracranial hypertension.
Sinclair AJ; Burdon MA; Nightingale PG; Matthews TD; Jacks A; Lawden M; Sivaguru A; Gaskin BJ; Rauz S; Clarke CE; Ball AK
J Neurol; 2012 Jul; 259(7):1406-12. PubMed ID: 22237821
[TBL] [Abstract][Full Text] [Related]
7. Optic disc haemorrhages at baseline as a risk factor for poor outcome in the Idiopathic Intracranial Hypertension Treatment Trial.
Wall M; Thurtell MJ;
Br J Ophthalmol; 2017 Sep; 101(9):1256-1260. PubMed ID: 28130349
[TBL] [Abstract][Full Text] [Related]
8. Superonasal Transconjunctival Optic Nerve Sheath Decompression: A Simplified Technique for Safe and Efficient Decompression.
Melson AT; Warmath JD; Moreau A; Farris BK
J Neuroophthalmol; 2021 Mar; 41(1):e16-e21. PubMed ID: 32141981
[TBL] [Abstract][Full Text] [Related]
9. Can Lumbar Puncture Be Safely Deferred in Patients With Mild Presumed Idiopathic Intracranial Hypertension?
Vosoughi AR; Margolin EA; Micieli JA
J Neuroophthalmol; 2022 Dec; 42(4):505-508. PubMed ID: 34860748
[TBL] [Abstract][Full Text] [Related]
10. Contrast-Enhanced 3D-FLAIR Imaging of the Optic Nerve and Optic Nerve Head: Novel Neuroimaging Findings of Idiopathic Intracranial Hypertension.
Golden E; Krivochenitser R; Mathews N; Longhurst C; Chen Y; Yu JJ; Kennedy TA
AJNR Am J Neuroradiol; 2019 Feb; 40(2):334-339. PubMed ID: 30679213
[TBL] [Abstract][Full Text] [Related]
11. Retinal Manifestations of Idiopathic Intracranial Hypertension.
Nichani P; Micieli JA
Ophthalmol Retina; 2021 May; 5(5):429-437. PubMed ID: 32860958
[TBL] [Abstract][Full Text] [Related]
12. The Relationship Between Optic Disc Volume, Area, and Frisén Score in Patients With Idiopathic Intracranial Hypertension.
Sheils CR; Fischer WS; Hollar RA; Blanchard LM; Feldon SE;
Am J Ophthalmol; 2018 Nov; 195():101-109. PubMed ID: 30081012
[TBL] [Abstract][Full Text] [Related]
13. Concomitant optic disk drusen and papilledema due to idiopathic intracranial hypertension in a pediatric cohort.
Tavakoli M; Yan F; Tauscher R
J AAPOS; 2024 Feb; 28(1):103806. PubMed ID: 38216114
[TBL] [Abstract][Full Text] [Related]
14. Long-term follow-up of idiopathic intracranial hypertension: the Iowa experience.
Shah VA; Kardon RH; Lee AG; Corbett JJ; Wall M
Neurology; 2008 Feb; 70(8):634-40. PubMed ID: 18285538
[TBL] [Abstract][Full Text] [Related]
15. Optic Nerve Head Volumetry by Optical Coherence Tomography in Papilledema Related to Idiopathic Intracranial Hypertension.
Dreesbach M; Joachimsen L; Küchlin S; Reich M; Gross NJ; Brandt AU; Schuchardt F; Harloff A; Böhringer D; Lagrèze WA
Transl Vis Sci Technol; 2020 Feb; 9(3):24. PubMed ID: 32742754
[TBL] [Abstract][Full Text] [Related]
16. Association between visual parameters and neuroimaging features of idiopathic intracranial hypertension.
Padhye LV; Van Stavern GP; Sharma A; Viets R; Huecker JB; Gordon MO
J Neurol Sci; 2013 Sep; 332(1-2):80-5. PubMed ID: 23850064
[TBL] [Abstract][Full Text] [Related]
17. Sonographic and ophthalmic assessment of optic nerve in patients with idiopathic intracranial hypertension: A longitudinal study.
Knodel S; Roemer SN; Moslemani K; Wykrota A; Käsmann-Kellner B; Seitz B; Wagenpfeil G; Fassbender K; Naldi A; Kalampokini S; Lochner P
J Neurol Sci; 2021 Nov; 430():118069. PubMed ID: 34525433
[TBL] [Abstract][Full Text] [Related]
18. Peripapillary microperimetry for the diagnosis and follow-up of papilledema in cases treated for idiopathic intracranial hypertension.
Elnahry GA; Elemary AM; Badr Eldin N; Nossair AA; Barrada OA; Elnahry AG
Neurol Res; 2021 Jan; 43(1):61-70. PubMed ID: 32915708
[TBL] [Abstract][Full Text] [Related]
19. Venous Sinus Stenting in Idiopathic Intracranial Hypertension: Results of a Prospective Trial.
Dinkin MJ; Patsalides A
J Neuroophthalmol; 2017 Jun; 37(2):113-121. PubMed ID: 27556959
[TBL] [Abstract][Full Text] [Related]
20. Baseline OCT measurements in the idiopathic intracranial hypertension treatment trial, part II: correlations and relationship to clinical features.
; Auinger P; Durbin M; Feldon S; Garvin M; Kardon R; Keltner J; Kupersmith MJ; Sibony P; Plumb K; Wang JK; Werner JS
Invest Ophthalmol Vis Sci; 2014 Nov; 55(12):8173-9. PubMed ID: 25370513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]